MSR79 Matching Plus Regression Adjustment for the Estimation of the Average Treatment Effect on Survival Outcomes: A Case Study with Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2138
https://www.valueinhealthjournal.com/article/S1098-3015(23)05268-3/fulltext
Title :
MSR79 Matching Plus Regression Adjustment for the Estimation of the Average Treatment Effect on Survival Outcomes: A Case Study with Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05268-3&doi=10.1016/j.jval.2023.09.2138
First page :
Section Title :
Open access? :
No
Section Order :
11583